Page last updated: 2024-08-23

elliptinium and Experimental Neoplasms

elliptinium has been researched along with Experimental Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (66.67)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bisagni, E; Chermann, JC; Ducrocq, C; Pochon, F; Rivalle, C; Tambourin, P; Tourbez-Perrin, M; Wendling, F	1
Amiel, JL; Dat-Xuong, N; Garnier, H; Juret, P; Le Pecq, JB; Paoletti, C; Rouesse, J	1
Atassi, G; Bisagni, E; Burbridge, M; Guilbaud, N; Jan, M; Kraus-Berthier, L; Pierré, A; Rouillon, MH; Saint-Dizier, D; Visalli, M	1

Reviews

1 review(s) available for elliptinium and Experimental Neoplasms

Article	Year
Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137). Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1980, Volume: 74 Topics: Alkaloids; Animals; Antineoplastic Agents; Drug Evaluation; Drug Evaluation, Preclinical; Ellipticines; Humans; Mice; Neoplasms; Neoplasms, Experimental; Rats	1980

Article

Year

Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137).

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1980, Volume: 74

Topics: Alkaloids; Animals; Antineoplastic Agents; Drug Evaluation; Drug Evaluation, Preclinical; Ellipticines; Humans; Mice; Neoplasms; Neoplasms, Experimental; Rats

1980

Other Studies

2 other study(ies) available for elliptinium and Experimental Neoplasms

Article	Year
Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives. Journal of medicinal chemistry, 1980, Volume: 23, Issue:11 Topics: Alkaloids; Animals; Antineoplastic Agents; Cell Survival; Chemical Phenomena; Chemistry; Ellipticines; Lethal Dose 50; Mice; Neoplasms, Experimental; Structure-Activity Relationship	1980
In vivo antitumor activity of S 16020-2, a new olivacine derivative. Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:6 Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Blood Cell Count; Bone Marrow; Breast Neoplasms; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Ellipticines; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Leukemia P388; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Tumor Cells, Cultured	1996

Article

Year

Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives.

Journal of medicinal chemistry, 1980, Volume: 23, Issue:11

Topics: Alkaloids; Animals; Antineoplastic Agents; Cell Survival; Chemical Phenomena; Chemistry; Ellipticines; Lethal Dose 50; Mice; Neoplasms, Experimental; Structure-Activity Relationship

1980

In vivo antitumor activity of S 16020-2, a new olivacine derivative.

Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:6

Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Blood Cell Count; Bone Marrow; Breast Neoplasms; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Ellipticines; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Leukemia P388; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Tumor Cells, Cultured

1996